CD4 and neoplasm: A detailed analysis of 29 immune cell subtypes revealed that the SL group displayed a greater abundance of antitumoral immune cells, notably CD8 + T cells (P < 0.01), CD4 + effector memory T cells, NK cells, M1 macrophages, and dendritic cells, which are known to contribute to effective immune surveillance and tumor rejection.